T-cell subset counting and the fight against AIDS: Reflections over a 20-year struggle

被引:33
作者
Mandy, F [1 ]
Nicholson, J
Autran, B
Janossy, G
机构
[1] Hlth Canada, Natl HIV Immunol Lab, Ottawa, ON K1A 0L2, Canada
[2] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA
[3] INSERM 543, Lab Immunol Cellulaire Pr Debre, Paris, France
[4] UCL Royal Free & Univ Coll Med Sch, Dept Immunol & Mol Pathol, London, England
来源
CYTOMETRY | 2002年 / 50卷 / 02期
关键词
CD4 T lymphocytes; HIV; flow cytometry; history of medicine; immunophenotyping gating strategies; naive/memory T cells;
D O I
10.1002/cyto.10097
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The story of T-lymphocyte subset immunophenotyping technology is reviewed on the occasion of the 20th anniversary of CD4 T-cell enumeration. Overtime, immunophenotyping has evolved into precise, reliable, but complicated and expensive technology requiring fresh blood samples. The gating technologies that were universally adapted for clinical flow cytometry for the past decade relied on rapidly deteriorating morphological scatter characteristics of leukocytes. This special issue dedicated to CD4 T-cell enumeration features most of the available new options that will have a significant impact on how this technology will be implemented within the first decade of the 21st century. In a series of original publications, including the new NIH guideline for T-cell subset enumeration, contemporary gating protocols that use immunologically logical parameters are presented as part of the more reliable and affordable immunophenotyping alternative. Some of the improvements addressed here include the costs of the assays and the capacity to monitor interlaboratory and intralaboratory performances. It is clear that an effective attack on the human immunodeficiency virus (HIV) epidemic has to embrace resource-poor regions. Reducing the cost of the assay while improving reliability and durability is a move in the right direction. Cytometry (Clin. Cytometry) 50: 39-45, 2002. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 62 条
[1]  
[Anonymous], 1926, Microbe Hunters
[2]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[3]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[4]   INTERCONVERSION OF CD45R SUBSETS OF CD4 T-CELLS INVIVO [J].
BELL, EB ;
SPARSHOTT, SM .
NATURE, 1990, 348 (6297) :163-166
[5]   Evaluation of a universal template for single-platform absolute T-lymphocyte subset enumeration [J].
Bergeron, M ;
Faucher, S ;
Ding, T ;
Phaneuf, S ;
Mandy, F .
CYTOMETRY, 2002, 50 (02) :62-68
[6]   Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens [J].
Bergeron, M ;
Nicholson, JKA ;
Phaneuf, S ;
Ding, T ;
Soucy, N ;
Badley, AD ;
Foss, NCH ;
Mandy, F .
CYTOMETRY, 2002, 50 (02) :53-61
[7]  
Bernard A., 1984, LEUCOCYTE TYPING
[8]  
Brandt J, 2000, CATENA, V40, P1
[9]   T cell changes after combined nucleoside analogue therapy in HIV primary infection [J].
Carcelain, G ;
Blanc, C ;
Leibowitch, J ;
Mariot, P ;
Mathez, D ;
Schneider, V ;
Saimot, AG ;
Damond, F ;
Simon, F ;
Debré, P ;
Autran, B ;
Girard, PM .
AIDS, 1999, 13 (09) :1077-1081
[10]   Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine [J].
Collier, AC ;
Coombs, RW ;
Schoenfeld, DA ;
Bassett, RL ;
Timpone, J ;
Baruch, A ;
Jones, M ;
Facey, K ;
Whitacre, C ;
McAuliffe, VJ ;
Friedman, HM ;
Merigan, TC ;
Reichman, RC ;
Hooper, C ;
Corey, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (16) :1011-1017